Raymond James & Associates’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$387K Sell
2024
Q2
$216K Buy
2024
Q1
$194K Buy
2023
Q4
$161K Buy
2023
Q3
$137K Buy
2023
Q2
$146K Buy
2023
Q1
$144K Buy
2022
Q4
$142K Hold
2022
Q3
$95K Hold
2022
Q2
$135K Hold
2022
Q1
$184K Sell
2021
Q4
$165K Buy
2021
Q3
$151K Buy
2021
Q2
$146K Sell
2021
Q1
$241K Buy
2020
Q4
$165K Hold
2020
Q3
$134K Buy
2020
Q2
$64K Sell
2020
Q1
$38K Buy